Mycophenolate Mofetil Tablets
If you find any inaccurate information, please let us know by providing your feedback here

This article is compiled based on the United States Pharmacopeia (USP) – 2025 Edition
Issued and maintained by the United States Pharmacopeial Convention (USP)
1 DEFINITION
Mycophenolate mofetil Tablets contain NLT 94.0% and NMT 105.0% of the labeled amount of mycophenolate mofetil (C23H31NO7).
2 IDENTIFICATION
Change to read:
A. The UV spectrum of the major peak of the Sample solution corresponds to that of the Standard solution, as obtained in the Assay (USP 1-Aug-2023)
B. The retention time of the major peak of the Sample solution corresponds to that of the Standard solution, as obtained in the Assay.
3 ASSAY
Change to read:
PROCEDURE
Phosphoric acid solution: Phosphoric acid and water (3:50)
Triethylamine solution: Transfer 3 mL of triethylamine to 1000 mL of water. Adjust with Phosphoric acid solution to a pH of 5.3.
Mobile phase: Acetonitrile and Triethylamine solution (55:45)
Standard solution: 0.125 mg/mL of USP Mycophenolate Mofetil RS in acetonitrile
Sample stock solution: Nominally 2.5 mg/mL of mycophenolate mofetil prepared as follows. Transfer Tablets, equivalent to 2.5 g of mycophenolate mofetil, to a 1000-mL volumetric flask. Add 100 mL of water and shake mechanically for a minimum of 15 min. Add 700 mL of acetonitrile, sonicate for 15 min, and shake mechanically for 20 min. Dilute with acetonitrile to volume. (USP 1-Aug-2023)
Sample solution: Nominally 0.125 mg/mL of mycophenolate mofetil in acetonitrile from Sample stock solution. Pass through a nylon filter of 0.45-µm pore size and discard the first 5 mL of the filtrate (USP 1-Aug-2023)
Chromatographic system
(See Chromatography (621), System Suitability.)
Mode: LC
Detector: UV 250 nm. For Identification A, use a diode array detector in the range of 200-400 nm. (USP 1-Aug-2023)
Column: 4.6-mm x 25-cm; 5-µm packing LZ
Temperatures
Column: 45°
Autosampler: 10±5°
Flow rate: 1.5 mL/min
Injection volume: 20 µL
Run time: NLT 3 times the retention time of mycophenolate mofetil peak (USP 1-Aug-2023)
System suitability
Sample: Standard solution
Suitability requirements
Tailing factor: NMT 2
Relative standard deviation: NMT 2.0%
Analysis
Samples: Standard solution and Sample solution
Calculate the percentage of the labeled amount of mycophenolate mofetil (C23H31NO7) in the portion of Tablets taken:
Result = (ru /rs ) × (Cs /Cu ) × 100
ru = peak response of mycophenolate mofetil from the Sample solution
rs = peak response of mycophenolate mofetil from the Standard solution
Cs = concentration of USP Mycophenolate Mofetil RS in the Standard solution (mg/mL)
Cu = nominal concentration of mycophenolate mofetil in the Sample solution (mg/mL)
Acceptance criteria: 94.0%–105.0%
4 PERFORMANCE TESTS
Change to read:
DISSOLUTION (711)
Test 1
Medium: 0.1 N hydrochloric acid: 900 mL
Apparatus 2: 50 rpm
Times: 5 and 15 min
Standard solution: 0.55 mg/mL of USP Mycophenolate Mofetil RS in Medium
Sample solution: Pass a portion of the solution under test through a suitable filter of 0.45-um pore size.
Instrumental conditions
(See Ultraviolet-Visible Spectroscopy (857)) (USP 1-Aug-2023)
Mode: UV
Analytical wavelength: 304 nm
Path length: 0.1 cm
Blank: Medium
Analysis
Samples: Standard solution and Sample solution
Calculate the concentration (Ci) of mycophenolate mofetil (C23H31NO7) dissolved at each time point (i):
Result = (Au /As ) × Cs
Au = absorbance of the Sample solution
As = absorbance of the Standard solution
Cs = concentration of USP Mycophenolate Mofetil RS in the Standard solution (mg/mL)
Calculate the percentage of the labeled amount of mycophenolate mofetil (C23H31NO7) dissolved at each time point (i):
Result1 = C1 × V × (1/L) × 100
Result2 = {[C2 × (V − Vs )] + (C1 × Vs )} × (1/L) × 100
Ci = concentration of mycophenolate mofetil in the portion of sample withdrawn at the specied time (mg/mL)
V = volume of the Medium, 900 mL
L = label claim (mg/Tablet)
Vs = volume of the Sample solution withdrawn at each time point (mL)
Tolerances: See Table 1.
Table 1
| Time Point (i) | Time (min) | Tolerances (Q) |
| 1 | 5 | NLT 75% |
| 2 | 15 | NLT 85% |
Test 2: If the product complies with this test, the labeling indicates that it meets USP Dissolution Test 2.
Medium: 0.1 N hydrochloric acid; 900 mL, deaerated
Apparatus 2: 50 rpm
Times: 5 and 15 min
Diluted phosphoric acid: Transfer 5 mL of phosphoric acid to a 25-mL volumetric ask. Dilute with water to volume.
Buffer: 3.0 mL/L of triethylamine in water. Adjust with Diluted phosphoric acid to a pH of 5.3.
Mobile phase: Acetonitrile and Buffer (45:55)
Diluent: Acetonitrile and Buffer (20:80)
Standard stock solution: 0.56 mg/mL of USP Mycophenolate Mofetil RS in Medium
Standard solution: 0.11 mg/mL of USP Mycophenolate Mofetil RS in Diluent from the Standard stock solution
Sample solution: Pass a portion of the solution under test through a suitable lter of 0.45-µm pore size. Transfer 5 mL of the ltrate to a 25mL volumetric ask, and dilute with Diluent to volume.
Chromatographic system
(See Chromatography 〈621〉, System Suitability.)
Mode: LC
Detector: UV 250 nm
Column: 4.6-mm × 15-cm; 5-µm packing L7
Column temperature: 35°
Flow rate: 1.5 mL/min
Injection volume: 20 µL
Run time: NLT 2.5 times the retention time of mycophenolate mofetil peak (USP 1-Aug-2023)
System suitability
Sample: Standard solution
Suitability requirements
Tailing factor: NMT 2.0
Relative standard deviation: NMT 2.0%
Analysis
Samples: Standard solution and Sample solution
Calculate the concentration (Ci) of mycophenolate mofetil (C23H31NO7) dissolved at each time point (i):
Result = (ru /rs ) × Cs × D
ru = peak response of mycophenolate mofetil from the Sample solution
rs = peak response of mycophenolate mofetil from the Standard solution
Cs = concentration of USP Mycophenolate Mofetil RS in the Standard solution (mg/mL)
D = dilution factor of the Sample solution
Calculate the percentage of the labeled amount of mycophenolate mofetil (C23H31NO7) dissolved at each time point (i):
Result1 = C1 × V × (1/L) × 100
Result2 = {[C2 × (V − Vs )] + (C1 × Vs )} × (1/L) × 100
Ci = concentration of mycophenolate mofetil in the portion of sample withdrawn at the specied time (mg/mL)
V = volume of the Medium, 900 mL
L = label claim (mg/Tablet)
Vs = volume of the Sample solution withdrawn at each time point (mL)
Tolerances: See Table 2.
Table 2
| Time Point (i) | Time (min) | Tolerances (Q) |
| 1 | 5 | NLT 60% |
| 2 | 15 | NLT 80% |
Test 3: If the product complies with this test, the labeling indicates that it meets USP Dissolution Test 3.
Medium: 0.1 N hydrochloric acid; 900 mL
Apparatus 2: 50 rpm
Times: 5 and 15 min
Standard solution: 0.011 mg/mL of USP Mycophenolate Mofetil RS in Medium
Sample solution: Pass a portion of the solution under test through a suitable lter of 0.45-µm pore size. Dilute 2 mL of the ltrate with
Medium to 100 mL.
Instrumental conditions
(See Ultraviolet-Visible Spectroscopy 〈857〉.) (USP 1-Aug-2023)
Mode: UV
Analytical wavelength: 250 nm
Path length: 1 cm
Blank: Medium
Analysis
Samples: Standard solution and Sample solution
Calculate the concentration (Ci) of mycophenolate mofetil (C23H31NO7) dissolved at each time point (i):
Result = (Au /As ) × Cs × D
Au = absorbance of the Sample solution
As = absorbance of the Standard solution
Cs = concentration of USP Mycophenolate Mofetil RS in the Standard solution (mg/mL)
D = dilution factor of the Sample solution, 50
Calculate the percentage of the labeled amount of mycophenolate mofetil (C H NO ) dissolved at each time point (i):
Result1 = C1 × V × (1/L) × 100
Result2 = {[C2 × (V − Vs )] + (C1 × Vs )} × (1/L) × 100
Ci = concentration of mycophenolate mofetil in the portion of sample withdrawn at the specied time (mg/mL)
V = volume of the Medium, 900 mL
L = label claim (mg/Tablet)
Vs = volume of the Sample solution withdrawn at each time point (mL)
Tolerances: See Table 3.
Table 3
| Time Point (i) | Time (min) | Tolerances (Q) |
| 1 | 5 | NLT 70% |
| 2 | 15 | NLT 85% |
UNIFORMITY OF DOSAGE UNITS (905): Meet the requirements
5 IMPURITIES
Change to read:
ORGANIC IMPURITIES (USP 1-Aug-2023)
Mobile phase, Standard solution, Sample solution, and Chromatographic system: Proceed as directed in the Assay.
Sensitivity solution: 0.0625 µg/mL of USP Mycophenolate Mofetil RS from Standard solution (USP 1-Aug-2023) in acetonitrile
System suitability
Samples: Standard solution and Sensitivity solution
Suitability requirements
Tailing factor: NMT 2, Standard solution
Relative standard deviation: NMT 2.0%, Standard solution
Signal-to-noise ratio: NLT 10, Sensitivity solution
Analysis
(USP 1-Aug-2023)
Samples: Standard solution and Sample solution
Calculate the percentage of any specified and unspecified degradation product (USP 1-Aug-2023) in the portion of Tablets taken:
Result = (ru /rs ) × (Cs /Cu ) × (1/F) × 100
ru = peak response of each (USP 1-Aug-2023) impurity from the Sample solution
rs = peak response of mycophenolate mofetil from the Standard solution
Cs = concentration of USP Mycophenolate Mofetil RS in the Standard solution (mg/mL)
Cu = nominal concentration of mycophenolate mofetil in the Sample solution (mg/mL)
F = relative response factor (USP 1-Aug-2023) (see Table 4)
Acceptance criteria: See Table 4. The reporting threshold is 0.05%. (USP 1-Aug-2023)
Table 4
| Name | Relative Retention Time | Relative Response Factor | Acceptance Criteria, NMT (%) |
| Mycophenolic acida | 0.6 | 1.4 | 1.0 |
| (USP 1-Aug-2023) N-oxide analogb | 0.8 | 1.0 | 0.2 |
| Mycophenolate mofetil | 1.0 | - | - |
| Any unspecied degradation product (USP 1-Aug-2023) | - | 1.0 | 0.1 |
| Total degradation products | - | - | 1.5 |
a (E)-6-(1,3-Dihydro-4-hydroxy-6-methoxy-7-methyl-3-oxo-5-isobenzofuranyl)-4-methyl-4-hexenoic acid.
b 2-Morpholinoethyl (E)-6-(1,3-dihydro-4-hydroxy-6-methoxy-7-methyl-3-oxo-5-isobenzofuranyl)-4-methyl-4-hexenoate N-oxide.
Change to read:
LIMIT OF Z-MYCOPHENOLATE MOFETIL
[NOTE-Z-Mycophenolate mofetil is 2-Morpholinoethyl (Z)-6-(1,3-dihydro-4-hydroxy-6-methoxy-7-methyl-3-oxo-5-isobenzofuranyl)-4-methyl-4-hexenoate. (USP 1-Aug-2023)
Triethylamine solution: Proceed as directed in the Assay.
Mobile phase: Acetonitrile and Triethylamine solution (35:65)
Standard solution: 0.025 mg/mL of USP Mycophenolate Mofetil RS in acetonitrile
Sensitivity solution: 1.25 µg/mL of USP Mycophenolate Mofetil RS from Standard solution (USP 1-Aug-2023) in acetonitrile
Sample solution: Nominally 2.5 mg/mL of mycophenolate mofetil prepared as follows. Transfer Tablets, equivalent to 2.5 g of mycophenolate mofetil, to a 1000-ml volumetric flask. Add 100 mL of water and shake mechanically for a minimum of 15 min. Add 700 mL of acetonitrile, sonicate for 15 min, and shake mechanically for 20 min. Dilute with acetonitrile to volume. Pass through a nylon filter of 0.45-µm pore size, and discard the first 2 mL of the filtrate.
Chromatographic system
(See Chromatography (621), System Suitability.)
Mode: LC
Detector: UV 215 nm
Column: 4.6-mm x 15-cm; 3.5-µm packing 17
Column temperature: 60°
Flow rate: 1.5 mL/min
Injection volume: 10 µL
Run time: 1.7 times the retention time of the mycophenolate mofetil peak
System suitability
Samples: Standard solution and Sensitivity solution
[NOTE-The relative retention times for mycophenolate mofetil and Z-mycophenolate mofetil are 1.0 and 1.1, respectively.]
Suitability requirements
Tailing factor: NMT 2.0, Standard solution
Relative standard deviation: NMT 5.0%, Standard solution
Signal-to-noise ratio: NLT 10, Sensitivity solution
Analysis
Samples: Standard solution and Sample solution
Calculate the percentage of Z-mycophenolate mofetil in the portion of Tablets taken:
Result = (ru /rs ) × (Cs /Cu ) × 100
ru = peak response of Z-mycophenolate mofetil from the Sample solution
rs = peak response of mycophenolate mofetil from the Standard solution
Cs = concentration of USP Mycophenolate Mofetil RS in the Standard solution (mg/mL)
Cu = nominal concentration of mycophenolate mofetil in the Sample solution (mg/mL)
Acceptance criteria: NMT 0.10%
6 ADDITIONAL REQUIREMENTS
PACKAGING AND STORAGE: Preserve in well-closed, light-resistant containers, and store at controlled room temperature.
LABELING: When more than one Dissolution test is given, the labeling states the Dissolution test used only if Test 1 is not used.
USP REFERENCE STANDARDS (11)
USP Mycophenolate Mofetil RS

